OMass Therapeutics products

First-in-class Gasdermin D inhibitors – a pipeline in a product.

First-in-class solute carrier activator reducing seizures in epilepsy including rare epilepsies

First-in-class molecules driving novel anti-inflammatory biology in Inflammatory Bowel Disease.

OMass’ platform retains biological relevance at high resolution, delivering cell-system fidelity with cell-free precision.

Insurmountable ACTH antagonism for a best-in-class profile in rare endocrine disorders.